Avalo Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US05338F3064
USD
17.95
2.08 (13.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAvalo Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
13.11%
0.3%
1W
-3.23%
0.54%
1M
7.68%
-0.03%
YTD
141.59%
16.46%
1Y
80.22%
13.22%
3Y
214.91%
68.23%
5Y
-99.76%
86.81%
10Y
-99.76%
234.19%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
70.06%
0%
70.06%
6 Months
307.95%
0%
307.95%
1 Year
80.22%
0%
80.22%
2 Years
14.89%
0%
14.89%
3 Years
214.91%
0%
214.91%
4 Years
-99.65%
0%
-99.65%
5 Years
-99.76%
0%
-99.76%

Avalo Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary